Languido, Baby Girl .
HRN: 23-39-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2023
AMPICILLIN 250MG (VIAL)
02/04/2023
02/10/2023
IV
50mg
Q12
RDS, Prematurity
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes